Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21883709 | 0.87 | CYP1A2 (0.35) | MEN1KMT2A | |
| SCHEMBL24449800 | 0.84 | MEN1 (0.35) | CA1CA2CA4MEN1KMT2A | |
| SCHEMBL12482311 | 0.84 | MEN1 (0.35) | CA1CA2CA4MEN1KMT2A | |
| SCHEMBL18553076 | 0.81 | — | — | |
| SCHEMBL21903207 | 0.77 | PIK3CD (0.38) | MEN1KMT2A | |
| SCHEMBL21903208 | 0.72 | PIK3CD (0.35) | — | |
| SCHEMBL21164838 | 0.72 | SLC6A4 (0.30) | — | |
| SCHEMBL21910849 | 0.72 | CYP1A2 (0.34) | MEN1KMT2A | |
| SCHEMBL18934345 | 0.71 | — | — | |
| SCHEMBL23666349 | 0.71 | MEN1 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020137414-A1 | POLYACETAL RESIN COMPOSITION AND METHOD FOR PRODUCING POLYACETAL RESIN COMPOSITION | ポリプラスチックス株式会社 | 2020-07-02 | — | — | WO | disclosed |
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | DOW CORNING CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | SETDB1, SETD2, SETD1A | CA1 165/4885CA2 1991/4885CA4 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.